Aldeyra Therapeutics, Inc. (ALDX)
1.495
-0.08
(-4.78%)
USD |
NASDAQ |
Apr 29, 14:55
Aldeyra Therapeutics Research and Development Expense (TTM) : 25.66M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Rhythm Pharmaceuticals, Inc. | 166.89M |
| Pfizer Inc. | 10.25B |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Merck & Co., Inc. | 12.71B |
| ADMA Biologics, Inc. | 4.761M |